- Home
- MMA vs APM Comparison
MMA vs APM Comparison
Compare MMA & APM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MMA
- APM
- Stock Information
- Founded
- MMA 2013
- APM 2010
- Country
- MMA Australia
- APM United Kingdom
- Employees
- MMA N/A
- APM N/A
- Industry
- MMA
- APM Biotechnology: Pharmaceutical Preparations
- Sector
- MMA
- APM Health Care
- Exchange
- MMA Nasdaq
- APM Nasdaq
- Market Cap
- MMA 8.4M
- APM 6.7M
- IPO Year
- MMA 2024
- APM 2018
- Fundamental
- Price
- MMA $0.71
- APM $0.92
- Analyst Decision
- MMA
- APM
- Analyst Count
- MMA 0
- APM 0
- Target Price
- MMA N/A
- APM N/A
- AVG Volume (30 Days)
- MMA 37.2K
- APM 51.3K
- Earning Date
- MMA 01-21-2025
- APM 04-29-2025
- Dividend Yield
- MMA N/A
- APM N/A
- EPS Growth
- MMA N/A
- APM N/A
- EPS
- MMA N/A
- APM 0.00
- Revenue
- MMA $375,175.00
- APM N/A
- Revenue This Year
- MMA N/A
- APM $157,729.10
- Revenue Next Year
- MMA N/A
- APM N/A
- P/E Ratio
- MMA N/A
- APM $262.46
- Revenue Growth
- MMA 45.19
- APM N/A
- 52 Week Low
- MMA $0.60
- APM $0.46
- 52 Week High
- MMA $5.25
- APM $11.95
- Technical
- Relative Strength Index (RSI)
- MMA N/A
- APM 42.55
- Support Level
- MMA N/A
- APM $0.82
- Resistance Level
- MMA N/A
- APM $1.08
- Average True Range (ATR)
- MMA 0.00
- APM 0.09
- MACD
- MMA 0.00
- APM -0.00
- Stochastic Oscillator
- MMA 0.00
- APM 39.27
About MMA Alta Global Group Limited
Mixed Martial Arts Group Ltd formerly Alta Global Group Ltd is a technology company engaged in the provision and administration of mixed martial arts training programs, and gym programs. It provides subscription-based products and services, offering both B2B SaaS solutions and B2C products and programs, covering online engagement, online content, and immersive in-gym experiences. The company's business units are; Trainalta.com; Mixed Martial Arts.com; and Hype.Co, Mobile Marketing solution. Its Alta Platform serves as a comprehensive solution for martial arts and combat sports, offering a blend of four core products: the Warrior Training Program, UFC Fight Fit Program, Alta Academy, and the Alta Community.
About APM Aptorum Group Limited
Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in two segments: Therapeutics and Non-Therapeutics. The projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services.